Haleon (HLN) Interest Coverage Ratio (2021 - 2025)

Haleon's (HLN) quarterly Interest Coverage Ratio came in at 6.17 in Q4 2025, up 21.32% on a QoQ basis from 7.84 in Q4 2023.

Haleon (HLN) Interest Coverage Ratio (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Interest Coverage Ratio data on file, last reported at 6.17 in Q4 2025.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 6.17 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 9.66 (changed N/A YoY) and the FY2025 annual result came in at 7.09, up 23.49% from the prior year.
Interest Coverage Ratio improved to 6.17 in Q4 2025, from 7.84 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 4.15 in Q2 2023 to a low of 367.25 in Q4 2022.
A 4-year average of 107.89 and a median of 7.84 in 2023 frame the typical range for Interest Coverage Ratio.
Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 165.7% — and 2023, when it surged 97.86%.
Tracing HLN's Interest Coverage Ratio over 4 years: stood at 138.22 in 2021, then tumbled by 165.7% to 367.25 in 2022, then surged by 97.86% to 7.84 in 2023, then climbed by 21.32% to 6.17 in 2025.
The last three Interest Coverage Ratio figures came in at 6.17 (Q4 2025), 7.84 (Q4 2023), and 4.15 (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	-
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn	114.07
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Alkermes	8.15 Bn	7.49 Bn	397.90 Mn	0.71

Download Data